- Home
- Products
- Pathway
- Support
- Contact Us
PD-L1 expression and PD-1 checkpoint pathway in cancer
Core of basic research: Clarify the immune escape mechanism by which tumor cells inhibit T cell activity through PD-L1 binding to PD-1 on immune cells, explore the regulation of PD-L1 expression by cytokines such as IFN-γ, as well as the mechanism of action and resistance of PD-1/PD-L1 inhibitors.
Core key proteins: PD-1 (inhibitory receptor on T cells), PD-L1 (ligand on tumor cells binding to PD-1), CTLA-4 (auxiliary immune checkpoint), TCR (T cell receptor for signal transduction), CD28 (T cell co-stimulatory molecule), IFN-γ (cytokine inducing PD-L1 expression), STAT1 (factor regulating PD-L1 transcription).
Core key proteins: PD-1 (inhibitory receptor on T cells), PD-L1 (ligand on tumor cells binding to PD-1), CTLA-4 (auxiliary immune checkpoint), TCR (T cell receptor for signal transduction), CD28 (T cell co-stimulatory molecule), IFN-γ (cytokine inducing PD-L1 expression), STAT1 (factor regulating PD-L1 transcription).
Product list
-
{{item.title}}{{item.react}}{{item.applicat}}
Product list
Product name
Reactivity
Application
Related Resource Links
Related Promotional Journal Downloads
Explore Our Recommended Popular Products
More products
30,000+ high- quality products available online
Primary Antibodies, Secondary Antibodies, mIHC Kits, ELISA Kits, Proteins, Molecular Biology Products，Cell Lines，Reagents ...
Contact Us
-
400-801-6722
-
support@lamarck.cn
-
Order
-
Message